• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Tobacco Products

Menthol Cigarettes

Menthol is a flavor additive widely used in consumer and medicinal products; however, its use in tobacco products is not currently regulated. It has a minty taste and aroma, and may have cooling or painkilling properties – which can reduce the irritation and harshness of smoking when used in cigarettes. 

Inviting Public Input on Menthol in Cigarettes

Menthol cigarettes raise critical public health questions. On July 23, 2013, the FDA issued an Advance Notice of Proposed Rulemaking (ANPRM) to take public input on menthol in cigarettes. Specifically, the FDA is requested information to inform its thinking about potential regulatory options such as:

  • tobacco product standards;
  • sale and distribution restrictions; and
  • other regulatory actions and considerations.


The FDA also conducted a preliminary independent scientific evaluation of existing data and research on menthol cigarettes. The Preliminary Scientific Evaluation of the Possible Public Health Effects of Menthol Versus Nonmenthol Cigarettes addresses the association between menthol cigarettes and various outcomes, including: 

  • initiation;
  • addiction; and
  • cessation.

Click for full version

More than 40% of  youth smokers and 30% of all adult smokers report smoking menthol cigarettes in the United States. 



The preliminary scientific evaluation, along with other relevant scientific information on the topic of menthol, was included for 122 days in the docket for the ANPRM to give all interested parties an opportunity to comment. The FDA will consider all comments, data, research, and other information submitted to the docket to determine what, if any, regulatory action with respect to menthol in cigarettes is appropriate. If the FDA decides to issue a rule, the first step in that process would be a Notice of Proposed Rulemaking, which would give the public an opportunity to weigh in on the specifics of the proposed rule.


Supporting New Research

The FDA is committed to a science-based approach that addresses the public health issues raised by menthol cigarettes. To further the FDA’s understanding of the likely public health impact of the use of menthol in cigarettes, the FDA plans to support new research on the differences between menthol and nonmenthol cigarettes, including:

  • menthol’s likely impact on smoking cessation;
  • menthol’s likely impact on attempts to quit; and
  • the levels of menthol in cigarette brands and subbrands.
The agency is also funding three menthol-related studies: 

Information received in response to the ANPRM, as well as new scientific research, will help the agency make the best decisions about possible regulatory actions.